A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy.
Jeong SH, Yeon SE, Kim SY, Kwon TG, Jeon SS, Choi YD, Kwon D, Chung BH, Hong SH, Kim BH, Lee HJ, Shin SJ, Choi WS, Park SW, Kang TW, Yun SJ, Cho JS, Choi SM, Lee NR, Kwak C.
Jeong SH, et al. Among authors: choi ws, choi yd, choi sm.
Investig Clin Urol. 2023 Sep;64(5):466-473. doi: 10.4111/icu.20230128.
Investig Clin Urol. 2023.
PMID: 37668202
Free PMC article.